National Institute of Nursing Research; Notice to Close Meeting, 26489 [2018-12177]
Download as PDF
Federal Register / Vol. 83, No. 110 / Thursday, June 7, 2018 / Notices
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
NIMH Psychoactive Drug Screening Program
(PDSP).
Date: June 19, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Vinod Charles, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6151, MSC 9606,
Bethesda, MD 20892–9606, 301–443–1606,
charlesvi@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: May 31, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–12176 Filed 6–6–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
sradovich on DSK3GMQ082PROD with NOTICES
National Institutes of Health
End of the Call for Participation for
Computational Photography Project
for Pill Identification (C3PI)
AGENCY:
National Institutes of Health,
With the successful
completion of the 2016 Pill Image
Recognition Challenge, the National
Library of Medicine (NLM) gratefully
acknowledges the pharmaceutical
manufacturers, re-packagers,
wholesalers, and retail and institutional
pharmacies that submitted prescription
drug products for imaging as part of its
Computational Photography Project for
Pill Identification (C3PI). Effective
immediately, the NLM is concluding its
collection of digital imagery of C3PI oral
solid dosage formulations (OSDFs),
discontinuing the program, and is no
longer accepting prescription drug
products for photography.
SUMMARY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Any
question regarding C3PI and its
discontinuation should be sent to: Dr.
Terry Yoo at splimage@nlm.nih.gov,
301–827–4976.
FOR FURTHER INFORMATION CONTACT:
C3PI
developed information infrastructure
and computational tools for identifying
pills from digital photographs and
associated data. C3PI issued a Pill Image
Recognition (PIR) computer vision
challenge in January 2016, seeking
software solutions for the content-based
information retrieval of drug
information from images submitted as
queries. NLM quantitatively evaluated
the resulting entries and awarded prizes
to the winners. The findings from the
PIR challenge were published in
October 2016. See https://
www.ncbi.nlm.nih.gov/pmc/articles/
PMC5973812/.
NLM is ending the project. No future
prescription drug products will be
accepted. Digital images will not be
obtained of drug products that may have
been submitted but not photographed as
of the termination of this project.
Previous NLM Imaging Initiative
Superseded: This notice supersedes all
prior instructions provided by 79 FR
56381–56382 https://
www.federalregister.gov/documents/
2014/09/19/2014-22308/call-forparticipation-for-computationalphotography-project-for-pillidentification-c3pi, published on
September 19, 2014.
SUPPLEMENTARY INFORMATION:
Dated: June 1, 2018.
Patricia Brennan,
Director, National Library of Medicine,
National Institutes of Health.
[FR Doc. 2018–12273 Filed 6–6–18; 8:45 am]
BILLING CODE 4140–01–P
HHS.
ACTION:
Notice.
VerDate Sep<11>2014
17:19 Jun 06, 2018
Jkt 244001
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
26489
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research;
Notice to Close Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Nursing Research Initial Review Group.
Date: June 21, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Weiqun Li, MD, Scientific
Review Officer, National Institute of Nursing
Research, National Institutes of Health, 6701
Democracy Blvd., Suite 710, Bethesda, MD
20892, (301) 594–5966, wli@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
Dated: June 1, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–12177 Filed 6–6–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
E:\FR\FM\07JNN1.SGM
07JNN1
Agencies
[Federal Register Volume 83, Number 110 (Thursday, June 7, 2018)]
[Notices]
[Page 26489]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-12177]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research; Notice to Close Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Nursing Research
Initial Review Group.
Date: June 21, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Bethesda, MD 20817.
Contact Person: Weiqun Li, MD, Scientific Review Officer,
National Institute of Nursing Research, National Institutes of
Health, 6701 Democracy Blvd., Suite 710, Bethesda, MD 20892, (301)
594-5966, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.361,
Nursing Research, National Institutes of Health, HHS)
Dated: June 1, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-12177 Filed 6-6-18; 8:45 am]
BILLING CODE 4140-01-P